IRCT20141025019669N11已完成3 期
The effects of oral supplementation ellagic acid on anti-oxidant status, inflammatory markers, and quality of life in a patient with irritabe bowel syndrome: randomized double-blind clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 years 至 60 years（—）
- 性别
- All
入选标准
- •Men and women with irritable bowel syndrome
排除标准
- •Patients with gastrointestinal problems such as celiac disease and infection of the gastrointestinal tract
研究者
相似试验
已完成
3 期
Ellagic acid supplementation in women with the poly cystic ovarian syndromePolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20141025019669N12Qazvin University of Medical Sciences60
招募中
3 期
Ellagic acid supplementation effect in patients with Major DepressiveMajor depressive episode.Major depressive disorder, single episodeIRCT20141025019669N15Mazandaran University of Medical Sciences60
招募中
3 期
Ellagic acid supplementation in patients with non-alcoholic fatty liver diseaseon alcoholic fatty liver disease.Other specified inflammatory liver diseasesK75.8IRCT20141025019669N21Qazvin University of Medical Sciences44
招募中
3 期
Ellagic acid supplementation effect in patients with type 2 diabetesIRCT20141025019669N13Qazvin University of Medical Sciences44
尚未招募
3 期
Ellagic acid in multiple sclerosisMultiple sclerosisIRCT20120415009472N22Iran University of Medical Sciences46